HAEGARDA®

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Product Information	Educational Materials	Conferences and Events	Key Publications

Exploring Patient Treatment Experience with Subcutaneous C1INH Prophylaxis for Hereditary Angioedema:
Impact on Breakthrough Attacks, Quality of Life, and Rescue Medication Use

View Poster

Please see full prescribing information for HAEGARDA

Retrospective Analysis of Patient Outcomes Associated with Subcutaneous C1INH Prophylaxis for Hereditary Angioedema

View Poster

Please see full prescribing information for HAEGARDA

Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis

^{Tap Image to view Graphical Abstract}

Lumry, W et al.
Allergy Asthma Clin Immunol. 2023
Request | Ask a Question | View Article

Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema

Prophylactic Therapy With Subcutaneous C1-Inhibitor Is Associated With Sustained Symptom Control in Patients With Hereditary Angioedema: Data up to ~2.7 Years
^{Tap Image to view Graphical Abstract}

Craig, Timothy et al.
Allergy Asthma Proc. 2022
Request | Ask a Question | View Article

Long-term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks

Craig T, Zuraw B, Longhurst H, et al.
J Allergy Clin Immunol Pract 2019
Request | Ask a Question | View Article

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

Longhurst H, Cicardi M, Craig T, et al.
N Engl J Med 2017
Request | Ask a Question | View Article

Posters

Key Publications